Addiction

KindlyMD to Present at Upcoming August 2024 Investor Conferences

SALT LAKE CITY, UT / ACCESSWIRE / August 13, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first…

3 months ago

TEDCO’s Maryland Innovation Initiative (MII) Announces Recent Investments

$2.1M invested in seven companies to advance innovations from lab to market in Maryland COLUMBIA, Md., Aug. 13, 2024 /PRNewswire/…

3 months ago

Compassion Center Expresses Gratitude to Rebecca Siewert of N.W. Classic and Woodburn Property Management for Highlighting Housing Disparities in Oregon

Compassion Center, headquartered in Hillsboro, Oregon, is a pioneer in integrative healthcare, dedicated to improving global quality of life through…

3 months ago

WVU Medicine To Host Brain-Machine Interface (BMI) Summit Charting the Future of Neurotechnology

Leading Neuroscientists, Technologists, Regulators, and Venture Capitalists Convening in West Virginia MORGANTOWN, W.Va., Aug. 9, 2024 /PRNewswire/ -- West Virginia…

4 months ago

Awakn Announces First Patient Screened in Phase 3 Clinical Trial of AWKN-001 for Severe Alcohol Use Disorder

Toronto, Ontario--(Newsfile Corp. - August 9, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…

4 months ago

Kipu Health Launches Medication Assisted Treatment (MAT) Solution Improving Care Experience for Patients in Opioid Treatment Programs (OTPs)

New solution to improve patient treatment unveiled at the United States Association of Opioid Treatment Providers (USAOTP) Annual Conference  AUSTIN,…

4 months ago

ACCP Position Statement: “Unregulated Psychotropic Products”

ASHBURN, Va., Aug. 7, 2024 /PRNewswire/ -- The American College of Clinical Pharmacology® (ACCP) published a recent Position Paper entitled "Unregulated…

4 months ago

Adial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Patient dosing has concluded for the second and last cohort of the pharmacokinetics study of AD04 Topline results expected during…

4 months ago

Speranza Therapeutics and CoAssist Pharmacy join the fight against the opioid crisis through patient access to non-invasive therapy

Partnership delivers innovative reimbursement options for S.T. Genesis, a medical device indicated for opioid withdrawal symptom managementBOCA RATON, Fla., Aug.…

4 months ago

atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference

NEW YORK and BERLIN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical…

4 months ago